Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical notes on buspirone.

D De Maio1

  • 1Ospedale Multizonale Fatebenefratelli Oftalmico, Servizio Psichiatria dell'USL 751l, Milano.

Pharmacology, Biochemistry, and Behavior
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

New non-benzodiazepine anxiolytic drugs offer targeted anxiety relief without sedative side effects. This allows for personalized treatment plans, empowering patients in managing generalized anxiety disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lithium ratio, phospholipids and the incidence of side effects.

Progress in neuro-psychopharmacology & biological psychiatry·1994
Same author

Lithium-TCA induced malignant syndrome. Case report.

Progress in neuro-psychopharmacology & biological psychiatry·1991
Same author

Notes on human behavioural pharmacotoxicology.

Progress in neuro-psychopharmacology & biological psychiatry·1988
Same author

Technological society: its impact on youth.

Topics in clinical nursing·1983
Same author

Evaluation of circadian, circaseptan, and circannual periodicity of attempted suicides.

Chronobiologia·1982
Same author

[Psychiatric experience in and outside the hospital at the Fatebenefratelli Hospital in Milan].

Annales medico-psychologiques·1980

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Traditional benzodiazepines for anxiety often cause side effects like sedation.
  • The need for anxiolytic medications with improved safety and efficacy profiles is critical.
  • Advances in drug development are exploring novel mechanisms for anxiety treatment.

Purpose of the Study:

  • To review recent developments in non-benzodiazepine anxiolytic drug discovery.
  • To highlight drugs with anxioselective properties and reduced benzodiazepine-related side effects.
  • To discuss the potential for guided anxiolysis and enhanced patient involvement in treatment.

Main Methods:

  • Review of recent pharmacological and clinical studies on anxiolytic agents.
  • Analysis of drug profiles focusing on anxiolytic vs. hypnotic activity.

Related Experiment Videos

  • Examination of the therapeutic applications and patient-centered approaches.

    • Main Results:

    • Development of non-benzodiazepine drugs with distinct anxioselective profiles.
    • Successful separation of anxiolytic effects from hypnotic or sedative properties.
    • Identification of specific agents, like buspirone, for generalized anxiety disorders.

    Conclusions:

    • Non-benzodiazepine anxiolytics represent a significant advancement in anxiety treatment.
    • These drugs enable a more targeted and less sedating approach to anxiolysis.
    • The development facilitates planned anxiolysis, encouraging greater patient engagement in therapy.